(Q45734454)

English

Immunization with type 5 adenovirus recombinant for a tumor antigen in combination with recombinant canarypox virus (ALVAC) cytokine gene delivery induces destruction of established prostate tumors

scientific article published in December 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Immunization with type 5 adenovirus recombinant for a tumor antigen in combination with recombinant canarypox virus (ALVAC) cytokine gene delivery induces destruction of established prostate tumors (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

0 references

1 reference

based on heuristic

inferred from title

Canarypox virus

object named as

canarypox virus

1 reference

based on heuristic

inferred from title

author name string

B D Elzey

1

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

D R Siemens

2

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

T L Ratliff

3

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

D M Lubaroff

4

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

language of work or name

0 references

publication date

1 December 2001

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

International Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

94

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

842-849

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Molecular forms of prostate-specific antigen and the human kallikrein gene family: a new era.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1556

21 January 2018

Hormonal regulation of prostate-specific antigen (PSA) glycoprotein in the human prostatic adenocarcinoma cell line, LNCaP

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1556

21 January 2018

Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1556

21 January 2018

Cancer statistics, 2000.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1556

21 January 2018

Expression of human prostate-specific antigen (PSA) in a mouse tumor cell line reduces tumorigenicity and elicits PSA-specific cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1556

21 January 2018

A recombinant vaccinia virus expressing human prostate‐specific antigen (PSA): Safety and immunogenicity in a non‐human primate

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1556

21 January 2018

In vitro generation of human cytotoxic T lymphocytes specific for peptides derived from prostate-specific antigen

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1556

21 January 2018

Effect of canarypox virus (ALVAC)-mediated cytokine expression on murine prostate tumor growth

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1556

21 January 2018

Demonstration of a rational strategy for human prostate cancer gene therapy

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1556

21 January 2018

Manipulation of T cell costimulatory and inhibitory signals for immunotherapy of prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1556

21 January 2018

Autoaggression and tumor rejection: it takes more than self-specific T-cell activation.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1556

21 January 2018

Characterization of the gene for prostate-specific antigen, a human glandular kallikrein.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1556

21 January 2018

Expression of Escherichia coli beta-galactosidase and rat HPRT in the CNS of Macaca mulatta following adenoviral mediated gene transfer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1556

21 January 2018

A new technique for the assay of infectivity of human adenovirus 5 DNA

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1556

21 January 2018

Adenovirus-mediated in vivo gene transfer and expression in normal rat liver

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1556

21 January 2018

Genetic predisposition and mesenchymal-epithelial interactions in ras+myc-induced carcinogenesis in reconstituted mouse prostate.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1556

21 January 2018

A human beta-actin expression vector system directs high-level accumulation of antisense transcripts

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1556

21 January 2018

Induction of cytotoxic T lymphocytes by recombinant canarypox (ALVAC) and attenuated vaccinia (NYVAC) viruses expressing the HIV-1 envelope glycoprotein

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1556

21 January 2018

Persistence of memory CD8 T cells in MHC class I-deficient mice

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1556

21 January 2018

In vivo priming of two distinct antitumor effector populations: the role of MHC class I expression

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1556

21 January 2018

Viral vector delivery in solid-state vehicles: gene expression in a murine prostate cancer model

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1556

21 January 2018

Adenoviral vectors for gene transfer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1556

21 January 2018

Systemic administration of interleukin 2 enhances the therapeutic efficacy of dendritic cell-based tumor vaccines

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1556

21 January 2018

Human Dendritic Cells Transfected with RNA Encoding Prostate-Specific Antigen Stimulate Prostate-Specific CTL Responses In Vitro

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1556

21 January 2018

Analysis of fixation effects on immunohistochemical localization of prostatic specific antigen in human prostate

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1556

21 January 2018

Molecular and immunological analysis of genetic prostate specific antigen (PSA) vaccine

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1556

21 January 2018

Interleukin-2 transfected prostate cancer cells generate a local antitumor effect in vivo

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1556

21 January 2018

Eradication of established tumors by CD8+ T cell adoptive immunotherapy

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1556

21 January 2018

Recombinant vaccinia-PSA (PROSTVAC) can induce a prostate-specific immune response in androgen-modulated human prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1556

21 January 2018

Identifiers

10.1002/IJC.1556

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

release_uimkazxgpbbazdmq6cgfwulroq

1 reference

https://api.fatcat.wiki/v0/release/uimkazxgpbbazdmq6cgfwulroq

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45734454&oldid=2079072479"